MedPath

Cohort/Ethics Study of Patients With Severe Alcoholic Hepatitis Undergoing Early Liver Transplantation

Conditions
Transplant; Complication, Rejection
Liver Diseases, Alcoholic
Hepatitis, Alcoholic
Liver Diseases
Alcohol-Induced Disorders
Alcohol-Related Disorders
Transplant; Failure, Liver
Interventions
Procedure: liver transplant
Registration Number
NCT04234139
Lead Sponsor
Johns Hopkins University
Brief Summary

The purpose of this study is to develop a clinical understanding of early liver transplantation (ELT) for patients with severe alcoholic hepatitis (SAH) and identify the public's opinion regarding this practice.

Detailed Description

The research study is designed to improve the investigators' understanding of early liver transplantation for patients with severe alcoholic hepatitis. The goal of this research is twofold:

1. Establish a knowledge base necessary for appropriate liver transplant candidate selection by quantifying post-ELT mortality for SAH and compare to outcomes to liver transplantation for other indications

2. Develop an ethical framework for implementation of these transplants for SAH based on the opinions of healthcare providers and the general public.

Recruitment & Eligibility

Status
ENROLLING_BY_INVITATION
Sex
All
Target Recruitment
300
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Prospective Cohort 2liver transplantOrthotopic Liver Transplantation (OLT) in patient who present with Alcoholic Liver Disease (ALD)
Prospective Cohort 1liver transplantEarly Liver Transplantation (ELT) for patients who present with Severe Alcoholic Hepatitis (SAH)
Retrospective Cohortliver transplantEarly Liver Transplantation (ELT) for patients who presented with Severe Alcoholic Hepatitis (SAH)
Primary Outcome Measures
NameTimeMethod
Number of participants who survived within 1 year post-transplant1 years

Post-transplant survival within one year of the surgical procedure.

Secondary Outcome Measures
NameTimeMethod
Number of participants who self-report or have biochemically measured alcohol recidivism or relapse within 1 year post-transplant1 years

Self-reported or biochemically measured alcohol recidivism or relapse.

Trial Locations

Locations (1)

Johns Hopkins University

🇺🇸

Baltimore, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath